C Bellanné-Chantelot Selected Research

Hepatocyte Nuclear Factor 1-alpha (Hepatocyte Nuclear Factor 1 alpha)

2/2016	High-sensitivity C-reactive protein does not improve the differential diagnosis of HNF1A-MODY and familial young-onset type 2 diabetes: A grey zone analysis.
6/2002	Nine novel mutations in maturity-onset diabetes of the young (MODY) candidate genes in 22 Spanish families.
4/2000	Genetic and clinical characterisation of maturity-onset diabetes of the young in Spanish families.
1/2000	Identification of seven novel nucleotide variants in the hepatocyte nuclear factor-1alpha (TCF1) promoter region in MODY patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

C Bellanné-Chantelot Research Topics

Disease

11	Type 2 Diabetes Mellitus (MODY) 02/2017 - 01/2000
3	Congenital Hyperinsulinism 05/2015 - 03/2006
3	Noninsulin-dependent diabetes mellitus with deafness 08/2009 - 01/2004
2	Type 3 Maturity-Onset Diabetes of the Young 06/2002 - 04/2000
1	Atopic Dermatitis (Atopic Eczema) 10/2021
1	Intellectual Disability (Idiocy) 02/2017
1	Mason-Type Diabetes 02/2016
1	Hypoglycemia (Reactive Hypoglycemia) 12/2011
1	Birth Weight (Birth Weights) 12/2011
1	WHIM syndrome 02/2011
1	Agammaglobulinemia (Hypogammaglobulinemia) 02/2011
1	Infections 02/2011
1	Warts (Wart) 02/2011
1	Sensorineural Hearing Loss 08/2009
1	MELAS Syndrome (Syndrome, MELAS) 08/2009
1	Mitochondrial Diseases (Mitochondrial Disease) 09/2008
1	Beckwith-Wiedemann Syndrome (Exomphalos Macroglossia Gigantism Syndrome) 03/2006
1	Diabetes Mellitus 11/2005
1	Hyperammonemia 01/2005
1	Hyperinsulinism (Hyperinsulinemia) 01/2005
1	Hyperplasia 01/2005
1	Channelopathies 01/2005
1	Hypertension (High Blood Pressure) 11/2004
1	Autosomal Recessive 3 Severe Congenital Neutropenia 09/2004
1	Ketosis 01/2004
1	Body Weight (Weight, Body) 01/2004
1	Diabetic Retinopathy (Retinopathy, Diabetic) 04/2002
1	Obesity 08/2001
1	Glucose Intolerance 01/2001
1	Type 1 Maturity-Onset Diabetes of the Young 04/2000
1	Type 2 Maturity-Onset Diabetes of the Young 04/2000

Drug/Important Bio-Agent (IBA)

6	Insulin (Novolin)FDA Link 11/2010 - 04/2000
4	Hepatocyte Nuclear Factor 1-alpha (Hepatocyte Nuclear Factor 1 alpha)IBA 02/2016 - 01/2000
4	Diazoxide (Hyperstat)FDA Link 05/2015 - 11/2005
3	Potassium Channels (Potassium Channel)IBA 05/2015 - 01/2005
3	Mitochondrial DNA (mtDNA)IBA 08/2009 - 01/2004
3	GlucokinaseIBA 01/2005 - 04/2000
2	Hepatocyte Nuclear FactorsIBA 02/2017 - 04/2000
2	Retinaldehyde (Retinal)IBA 09/2008 - 04/2002
2	Glucose (Dextrose)FDA LinkGeneric 01/2001 - 04/2000
1	dupilumabIBA 10/2021
1	C-Reactive ProteinIBA 02/2016
1	CXCR4 Receptors (CXCR4 Receptor)IBA 02/2011
1	LigandsIBA 02/2011
1	Azithromycin (Zithromax)FDA LinkGeneric 02/2011
1	Biomarkers (Surrogate Marker)IBA 12/2010
1	EnzymesIBA 01/2005
1	Glutamate DehydrogenaseIBA 01/2005
1	Oxidoreductases (Dehydrogenase)IBA 01/2005
1	Insulin ReceptorIBA 01/2005
1	Triglycerides (Triacylglycerol)IBA 11/2004
1	CreatinineIBA 11/2004
1	peroxisome-proliferator-activated receptor-gamma coactivator-1IBA 11/2004
1	Granulocyte Colony-Stimulating Factor Receptors (G-CSF Receptor)IBA 09/2004
1	Hemoglobins (Hemoglobin)IBA 01/2004
1	Calcitriol Receptors (Calcitriol Receptor)IBA 08/2001
1	Vitamin D-Binding ProteinIBA 03/2001
1	Sulfonylurea ReceptorsIBA 08/2000
1	NucleotidesIBA 01/2000

Therapy/Procedure

1	Pancreatectomy 11/2005